SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's Laboratories moves higher on reporting marginal rise in Q1 consolidated net profit

24 Jul 2025 Evaluate

Dr Reddy's Laboratories is currently trading at Rs 1277.70, up by 30.15 points or 2.42% from its previous closing of Rs 1247.55 on the BSE.

The scrip opened at Rs 1255.05 and has touched a high and low of Rs 1287.90 and Rs 1255.05 respectively. So far 160774 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 1 has touched a 52-week high of Rs 1420.20 on 21-Aug-2024 and a 52-week low of Rs 1025.90 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs 1287.90 and Rs 1232.00 respectively. The current market cap of the company is Rs 106651.21 crore.

The promoters holding in the company stood at 26.64%, while Institutions and Non-Institutions held 52.07% and 10.26% respectively.

Dr Reddy's Laboratories has reported 2- fold jump in its net profit at Rs 2961.20 crore for the first quarter ended June 30, 2025 as compared to Rs 1417.20 crore for the same quarter in the previous year. Total income of the company increased by 35.46% at Rs 8207.80 crore for Q1FY26 as compared to Rs 6059.00 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 1.85% jump in net profit at Rs 1418.10 crore for Q1FY26 as compared to Rs 1392.40 crore for the same quarter in the previous year. Total income of the company increased by 12.41% at Rs 8862.40 crore for Q1FY26 as compared to Rs 7883.30 crore for the corresponding quarter previous year.

Dr. Reddys Lab Share Price

1220.75 -11.50 (-0.93%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×